{"ok":true,"article":{"slug":"fda-approves-iberdomide-the-first-celmod-for-relapsed-refractory-multiple-myelom-7b706e3c","title":"FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma","url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNNmlxV3VpTkRTZmp5eWFoWDJZQWl4eUJ5T1ZuSk1OYmhsSWJTNkxiWVFqV05MZ2NuSGdra2l0UzQ2em15RW9GZmJ4OEFyc1Q2T1MzRjZBaXU5a3J2WUEwdi1jWUx1Q0ZQSklNSno1cGhoMkV5ZXdWR2pkcHZNb2hDV0RxWkVEOThTVjVacGc4OG5sVnZleWpvOVlEbw?oc=5&hl=en-US&gl=US&ceid=US:en","canonical":"https://www.aimode.news/article/fda-approves-iberdomide-the-first-celmod-for-relapsed-refractory-multiple-myelom-7b706e3c","sourceName":"Targeted Oncology","summary":"Related coverage: FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma Targeted Oncology","category":"Health","image":null,"lang":"en","publishedAt":"2026-08-13T22:52:40+00:00","createdAt":"2026-08-13T23:00:12.799998+00:00"}}